Today, on World Cervical Cancer Elimination Day, Australia is proud that its contribution of K4.2 million is supporting Papua New Guinea’s historic rollout of the human papillomavirus (HPV) vaccine, strengthening our shared efforts to protect women and girls from cervical cancer.
Australia’s contribution will support the introduction and delivery of HPV vaccinations, as PNG works to reach an initial cohort of almost 900,000 girls aged 9–14 years across the country.
Cervical cancer is the second most common cancer among women in PNG, with around 1,053 new cases each year. The HPV vaccine offers an opportunity to dramatically reduce this burden for future generations.
Australia's contribution will help support healthcare workers to deliver a nationwide vaccination drive, as well as community engagement, training and supervision, including efforts to reach out-of-school and hard-to-reach girls.
Australia’s High Commissioner to Papua New Guinea, H.E. Jamie Isbister, said, “Australia is proud to support PNG’s roll out of the HPV vaccine for the first time. This game-changing vaccine, developed by Australian researchers, will provide a lifetime of protection against cervical cancer for young girls across the country.”
Working with the Government of PNG and technical partners including UNICEF, WHO, and Gavi, Australia is committed to helping PNG strengthen immunisation coverage and move closer to a future free from cervical cancer.
